Allison Lastinger
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Allison Lastinger has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
Ankur Makani
Department of Medicine, West Virginia University, Morgantown, WV, USA
1 shared publicationArif R Sarwari
Department of Medicine, West Virginia University
1 shared publication- Benjamin Giertych
Department of Orthopaedics, West Virginia University, Morgantown, WV, USA
1 shared publication - Benjamin M. Frye
West Virginia University, Department of Orthopaedics, 64 Medical Center Drive, PO Box 9196, Morgantown, WV 26506-9196, USA
1 shared publication - Brian Patrick Peppers
Interim Editor-in-Chief
1 shared publication - Catessa A. Howard
West Virginia University Medicine - WVU Hospitals, Department of Pharmacy Services, One Medical Center Drive, PO Box 8045, Morgantown, WV 26506-8045, USA
1 shared publication
Latest Publications
- 6 November 2026
- Published by British Editorial Society of Bone & Joint Surgery in Orthopaedic Proceedings
- Vol. 108-B (SUPP_11) , 108
EFFECT OF METABOLIC DERANGEMENT AND INFLAMMATORY CONDITIONS ON DIAGNOSTIC CRITERIA FOR SEPTIC ARTHRITIS
Introduction & Aim: Septic arthritis describes inflammation of the synovial capsule and represents a true orthopaedic emergency. There is no single diagnostic criteria for septic arthritis, although clinical presentation, in conjunction with synovial fluid analysis, is used to support the diagnosis. Traditional thresholds of synovial fluid analysis based on total nucleated cell counts (TNC) (>50,000 cells), polymorphonuclear (PMN) cell percentages (>90% PMN), and gram stain are commonly employed. However, there remains a paucity of information regarding how immune dysregulation of metabolic and/or inflammatory disorders affects the immune response in the synovial fluid, and subsequently, diagnostic criteria. The current study investigated whether immune dysregulation from metabolic and inflammatory conditions affect synovial characteristics. Methods: Patients >18 years of age diagnosed with septic arthritis between 01/01/2014 - 12/31/2024 were reviewed retrospectively to determine sources of immune dysregulation present at the time of diagnosis. Baseline patient characteristics, synovial fluid values, serum markers, and immune system classification were collected. Immune status characterizations included: cancer treatment, organ transplant recipient, medication-induced immunodeficiency, primary immunodeficiency, HIV infection, systemic illness (end-stage renal disease, decompensated cirrhosis, poorly controlled diabetes), and inflammatory conditions (rheumatoid arthritis, systemic Lupus erythematosus, or inflammatory bowel disease). Planned preliminary comparisons were made between immune status groups using ANOVA with post-hoc correction if significance was found at p<0.05. Results: 583 patients were returned in the initial search with 93 determined to have potential immune dysregulation: 62 chronic systemic disease (66.67%), 21 inflammatory conditions (22.58%), 4 undergoing active cancer treatment (4.30%), 2 primary immunodeficiency (2.15%), 1 organ transplant recipient (1.07%), 1 neutropenia (1.07%), 1 acquired immunodeficiency (1.07%), and 1 myelodysplastic syndrome (1.07%). Due to the small sample size in many of the groups, a student t-test was used to compare the chronic systemic disease and inflammatory condition patients only. Conclusion: Patients with chronic systemic disease and inflammatory conditions demonstrated variability in synovial and serum inflammatory markers with no statistically significant differences suggesting diagnostic criteria between the two may not differ. It is important to note that total nucleated cell counts were above the traditional 50,000 cell threshold for septic arthritis. These findings do not support changes to diagnostic criteria depending on presence of systemic disease or inflammatory condition. Therefore, larger cohorts are needed to better define these findings.
- 6 November 2026
- Published by British Editorial Society of Bone & Joint Surgery in Orthopaedic Proceedings
- Vol. 108-B (SUPP_11) , 108
EFFECT OF METABOLIC DERANGEMENT AND INFLAMMATORY CONDITIONS ON DIAGNOSTIC CRITERIA FOR SEPTIC ARTHRITIS
Introduction & Aim: Septic arthritis describes inflammation of the synovial capsule and represents a true orthopaedic emergency. There is no single diagnostic criteria for septic arthritis, although clinical presentation, in conjunction with synovial fluid analysis, is used to support the diagnosis. Traditional thresholds of synovial fluid analysis based on total nucleated cell counts (TNC) (>50,000 cells), polymorphonuclear (PMN) cell percentages (>90% PMN), and gram stain are commonly employed. However, there remains a paucity of information regarding how immune dysregulation of metabolic and/or inflammatory disorders affects the immune response in the synovial fluid, and subsequently, diagnostic criteria. The current study investigated whether immune dysregulation from metabolic and inflammatory conditions affect synovial characteristics. Methods: Patients >18 years of age diagnosed with septic arthritis between 01/01/2014 - 12/31/2024 were reviewed retrospectively to determine sources of immune dysregulation present at the time of diagnosis. Baseline patient characteristics, synovial fluid values, serum markers, and immune system classification were collected. Immune status characterizations included: cancer treatment, organ transplant recipient, medication-induced immunodeficiency, primary immunodeficiency, HIV infection, systemic illness (end-stage renal disease, decompensated cirrhosis, poorly controlled diabetes), and inflammatory conditions (rheumatoid arthritis, systemic Lupus erythematosus, or inflammatory bowel disease). Planned preliminary comparisons were made between immune status groups using ANOVA with post-hoc correction if significance was found at p<0.05. Results: 583 patients were returned in the initial search with 93 determined to have potential immune dysregulation: 62 chronic systemic disease (66.67%), 21 inflammatory conditions (22.58%), 4 undergoing active cancer treatment (4.30%), 2 primary immunodeficiency (2.15%), 1 organ transplant recipient (1.07%), 1 neutropenia (1.07%), 1 acquired immunodeficiency (1.07%), and 1 myelodysplastic syndrome (1.07%). Due to the small sample size in many of the groups, a student t-test was used to compare the chronic systemic disease and inflammatory condition patients only. Conclusion: Patients with chronic systemic disease and inflammatory conditions demonstrated variability in synovial and serum inflammatory markers with no statistically significant differences suggesting diagnostic criteria between the two may not differ. It is important to note that total nucleated cell counts were above the traditional 50,000 cell threshold for septic arthritis. These findings do not support changes to diagnostic criteria depending on presence of systemic disease or inflammatory condition. Therefore, larger cohorts are needed to better define these findings.
- 9 April 2026
- Published by Elsevier in The Journal of Arthroplasty
- Vol. 41 (10) , S133-S138
Standardizing Safe Cefazolin Use in Total Joint Arthroplasty: A Multidisciplinary Triage Protocol
- 9 April 2026
- Published by Elsevier in The Journal of Arthroplasty
- Vol. 41 (10) , S133-S138
Standardizing Safe Cefazolin Use in Total Joint Arthroplasty: A Multidisciplinary Triage Protocol
- Open Access
- 10 November 2023
- Published by Elsevier in Arthroplasty Today
- Vol. 24, 101255
A Pilot Study Using a Standardized Method of Measuring Distress Demonstrates Higher Levels in Septic Revisions
- 10 November 2023
- Published by Elsevier in Arthroplasty Today
- Vol. 24, 101255
Open AccessA Pilot Study Using a Standardized Method of Measuring Distress Demonstrates Higher Levels in Septic Revisions
- Open Access
- 21 May 2019
- Published by Copernicus GmbH in Journal of Bone and Joint Infection
- Vol. 4 (3) , 126-132
Clinical Experience with Tigecycline in the Treatment of Prosthetic Joint Infections
Purpose: The purpose of this study was to examine the use of tigecycline in the treatment of prosthetic joint infection (PJI).
- 21 May 2019
- Published by Copernicus GmbH in Journal of Bone and Joint Infection
- Vol. 4 (3) , 126-132
Open AccessClinical Experience with Tigecycline in the Treatment of Prosthetic Joint Infections
Purpose: The purpose of this study was to examine the use of tigecycline in the treatment of prosthetic joint infection (PJI).
- Open Access
Pyometra due to Pseudomonas aeruginosa
- 1 August 2017
- Published by Elsevier in American Journal of Infection Control
- Vol. 45 (8) , 824-829
Use of a patient empowerment tool for hand hygiene
- 1 August 2017
- Published by Elsevier in American Journal of Infection Control
- Vol. 45 (8) , 824-829
Use of a patient empowerment tool for hand hygiene
- Open Access
- 1 June 2016
- Published by Elsevier in Pediatrics & Neonatology
- Vol. 57 (3) , 236-239
Scimitar Syndrome and H-type Tracheo-esophageal Fistula in a Newborn Infant
- 1 June 2016
- Published by Elsevier in Pediatrics & Neonatology
- Vol. 57 (3) , 236-239
Open AccessScimitar Syndrome and H-type Tracheo-esophageal Fistula in a Newborn Infant